Study | Reason for exclusion |
---|---|
Joo 2008 | Tamsulosin versus no treatment for TWOC in spinal surgery patients electively catheterised perioperatively (not in acute urinary retention prior to surgery). |
Kraus 2010 | No catheters involved. Urodynamic assessment of daily tadalafil versus placebo on lower urinary tract symptoms. |
Lim 1999 | No alpha blockers used in study. Study describes outcome of TWOC in 79 untreated patients. |
Liu 2009 | No catheters involved as patients not in acute urinary retention. Randomised trial of amlodipine with or without terazosin for LUTS. |
Lorente 2004 | Use of increasing dosage of doxazosin in failed TWOC patients. 40 patients randomly assigned to doxazosin 4 mg once daily (n = 20) or no treatment (n = 20) for seven days before TWOC. Failed TWOC patients either received doxazosin 8mg (treatment group) or 4 mg (control group) once daily before a second TWOC. |
Martov 2010 | No catheters involved as study assessing tamsulosin for stent‐related irritative symptoms. |
McNeill 2004 | Long‐term follow‐up study of patient cohort who had successful TWOC following an episode of acute urinary retention (alfuzosin versus placebo). |
Taube 1989b | No alpha‐blockers used in study. Study describes outcome of TWOC immediately, after 24 and 48 hours in 60 untreated patients (subdivided into three groups). |
Wang 2009 | No catheters involved as study assessing effect of tamsulosin in patients with indwelling double‐J ureteral stents. |
LUTS = lower urinary tract symptoms TWOC = trial without catheter